OOIR: Observatory of International Research

Papers

(The TQCC of Menopause-The Journal of the North American Menopause Society is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)

Article	Citations
Reflecting on the enduring effects of childhood maltreatment	519
Validation of the Menopause Transition Scale (MTS)	142
The effect of probiotic administration on the severity of menopausal symptoms and mental health of postmenopausal women: a triple-blind randomized controlled trial in the West of Iran	60
Risk factors for delayed intrauterine device removal among menopausal women in rural China	32
Psychometric properties and validity of the Menopause Rating Scale in postmenopausal Portuguese women	27
Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis	24
Urban-rural differences in epidemiology and risk factors of menopause syndrome in middle-aged Chinese women	24
A call for health equity when addressing menopausal symptoms	22
Treating where it hurts: tailoring the genitourinary syndrome of menopause treatments	20
Dietary patterns and prevalence of multimorbidity in women in southern Brazil	19
Health screening of middle-aged women: what factors impact longevity?	18
Vitamin D supplements and prevalent overactive bladder in women from midlife through older ages	18
#Menopause: the menopause ontology project	18
Low-serum anti-Müllerian hormone in middle-aged women associates with obesity markers	16
Risk factors for future osteoporosis in perimenopausal Japanese women	16
The prevalence of osteoporosis in postmenopausal women in urban Tianjin, China and its related factors	16
The association of vasomotor symptoms during the menopausal transition and cognition in later life	15
Lessons Learned in Clinical Research Recruitment of Midlife Latinas During COVID-19	14
Menopause hormone therapy and urinary symptoms: a systematic review	14
Perimenopause meets life: observations from the Women Living Better Survey	14
Superficial dyspareunia treatment with hyperstacking of erbium:yttrium-aluminum-garnet SMOOTH laser: a short-term, pilot study in breast cancer survivors	14
Association between vitamin D and calcium intakes, breast microcalcifications, breast tissue age-related lobular involution and breast density	14
The association between hormone therapy and the risk of lung cancer in postmenopausal women: a 16-year nationwide population-based study	13
Examining long-term health impacts of multiparity	13
Quality of life in Spanish postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study	12

Pharmacological interactions and menopausal hormone therapy: a review	12
Exercise training and vascular function in postmenopausal individuals: a systematic review and meta-analysis	12
Association of parity with body mass index and cardiometabolic risk in high-parous women	12
Health care concerns in women at midlife: differences by race, ethnicity, and neighborhood socioeconomic status	12
Cytological characteristics of premalignant cervical epithelial lesions in postmenopausal women based on endocrine indices and parakeratosis	11
Impact of the CBT-Meno protocol on menopause-specific beliefs, dysfunctional attitudes, and coping behaviors	11
Risk of high depressive symptoms after the final menstrual period: the Study of Women’s Health Across the Nation (SWAN)	10
Perception of higher frequency of daily hot flashes in 50-year-old women today: a study of trends over time during 48 years in the Population Study of Women in Gothenburg, Sweden	10
Efficacy and safety of lemborexant in midlife women with insomnia disorder	10
Network analysis of eating disorder symptoms in women in perimenopause and early postmenopause	9
Letters to the editor	9
Screening for factors at midlife associated with reduced longevity in women	9
Indian physicians' attitudes and practice regarding menopause and its management: a focus group discussion	9
Isolated vitamin D supplementation improves the adipokine profile of postmenopausal women: a randomized clinical trial	8
Menopause hormone therapy and sarcodynapenia: the Canadian Longitudinal Study on Aging	8
Psychometric evaluation of the German Day-to-Day Impact of Vaginal Aging questionnaire using data from two intervention studies	8
Climacteric status is associated with sexual dysfunction at the age of 46 years: a population-based study	8
Impact of vitamin D supplementation on modulating heat-shock proteins in postmenopausal women: a randomized, double-blind, placebo-controlled study	8
Nonhormone treatments for vasomotor symptoms	8
Menopause: The Journal of The North American Menopause Society Volume 29, 2022	8
Postmenopausal giant ovarian tumor: a rare case report and literature review	8
Lipoprotein subfractions and subclinical vascular health in middle aged women: does menopause status matter?	8
Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update	7
Prasterone in the treatment of mild to moderate urge incontinence: an observational study	7
Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)	7
Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis	7
Hysterectomy with or without ovarian conservation: similar associations with vascular health?	7
Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea–based retrospective cohort study	7
Psychometric properties of a Persian version of the Vulvovaginal Symptoms Questionnaire for measuring vulvovaginal symptoms in postmenopausal women	7
Menopause for justice-involved women: consequences and care in prison systems	7
Genitourinary syndrome of menopause—I know it when I see it—or do I?	7
Should vitamin D supplements be prescribed routinely for midlife women?	6
Practice patterns and perspectives regarding treatment for symptoms of menopause: qualitative interviews with US health care providers	6
Prophylactic salpingectomy with delayed oophorectomy as a two-staged alternative for primary prevention of ovarian cancer in BRCA1/2 mutation carriers: women's point of view	6
The association between metabolic dysfunction–associated steatotic liver disease diagnosis and vasomotor symptoms in midlife women	6
Interactions between nutrient intake and comorbidities for quality of life in premenopausal and postmenopausal women	6
Composite dietary antioxidant intake and osteoporosis likelihood in premenopausal and postmenopausal women: a population-based study in the United States	6
Inflamm-aging or inflamm-opause: is inflammation the cause or consequence of vasomotor symptoms?	6
Update on estrogen therapy and prevention of bone loss	6
Uterine arcuate artery calcification as a potential marker of cardiovascular risk—a preliminary study	6
2022 Annual Meeting of The North American Menopause Society October 12 – 15, 2022, Atlanta, GA	6
Moving toward health equity: the influence of race and ethnicity on choice and quality of life of menopause treatment in midlife women	6